Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
Amyloid aggregation of mutant p53 contributes to its loss of tumor suppressor function and oncogenic gain-of-function. Here, the authors use a protein mimetic to abrogate mutant p53 aggregation and rescue p53 function, which inhibits cancer cell proliferation in vitro and halts tumor growth in vivo.
Guardado en:
Autores principales: | L. Palanikumar, Laura Karpauskaite, Mohamed Al-Sayegh, Ibrahim Chehade, Maheen Alam, Sarah Hassan, Debabrata Maity, Liaqat Ali, Mona Kalmouni, Yamanappa Hunashal, Jemil Ahmed, Tatiana Houhou, Shake Karapetyan, Zackary Falls, Ram Samudrala, Renu Pasricha, Gennaro Esposito, Ahmed J. Afzal, Andrew D. Hamilton, Sunil Kumar, Mazin Magzoub |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aabfbc8d47544f739652c54bd2eb3f1f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Classification of Abrogation in the Qur’an
por: Israr Ahmad Khan
Publicado: (2006) -
Abrogation of the Platt Amendment, 1934
Publicado: (2017) -
TABARÎ’S APPROACH TO THE JURISPRUDENCE AND ABROGATION
por: Naif YAŞAR
Publicado: (2019) -
Genome editing abrogates angiogenesis in vivo
por: Xionggao Huang, et al.
Publicado: (2017) -
TNIK inhibition abrogates colorectal cancer stemness
por: Mari Masuda, et al.
Publicado: (2016)